EUCTR2007-003244-30-NL进行中（未招募）不适用
Diazoxide-Mediated Insulin Suppression in Hyperinsulinemic Obese Men, part III.
Rijnstate Hospital0 个研究点开始时间: 2007年6月27日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •-BMI 30-35 kg/m2
- •-Age 25-50 years
- •-Stable body weight 3 months before participating in study
- •-Fasting glucose = 6.0 mmol/L
- •-Fastinge C-peptide = 1.0 nmol/L or in upper quartile of normal
- •-HbA1c = 6.0%
- •-No co-medication.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-creatinin > 120 µmol/L
- •-Liver enzyms > 2x upper limit of normal
- •-Alcohol > 2E/day
- •-Drugs abuse
- •-Cessation of smoking less than 6 months before participating in study
研究者
相似试验
已完成
2 期
DZX Mediated Insulin Suppression in Obese MenObesityNCT00631033Rijnstate Hospital51
已完成
2 期
Diazoxide-Mediated Insulin Suppression in Hyperinsulinemic Obese MenHyperinsulinismObesityNCT00151684Rijnstate Hospital25
已完成
不适用
Attenuation of glycemic and insulin response following tapioca resistant maltodextrin consumption in healthy subjects: A randomized cross-over controlled trialblood glucoseinsulinhungersatietyappetiteTCTR20200105004Thailand Research Fund18
进行中（未招募）
不适用
se of diazoxide in people with type 1 diabetes in acute hypoglycaemiaEUCTR2011-005011-93-GBniversity of Dundee and NHS Tayside
已完成
不适用
Inhibitory effect on elevation of blood glucose level by bonito dashiMen and women aged from 30 to 70 without a critical disease such as diabetes mellitus and having BMI less than 30.JPRN-UMIN000034776Tenshi College, School of Nursing and Nutrition, Department of Nutrition20